Who Paid My Doc
TNKase
Biological Metabolism & Primary Care
NDC 50242-120-01
General payments
$709,415
Research payments
$3,692,930
Through program year 2024, $709,415 in general payments and $3,692,930 in research payments were reported against TNKase (Metabolism & Primary Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $1,015 | 20 |
| 2024 | Research | $297,643 | 152 |
| 2023 | General | $89,538 | 63 |
| 2023 | Research | $999,174 | 381 |
| 2022 | General | $182,700 | 65 |
| 2022 | Research | $1,757,263 | 255 |
| 2021 | General | $55,663 | 35 |
| 2021 | Research | $38,823 | 11 |
| 2020 | General | $135,715 | 46 |
| 2020 | Research | $458,242 | 14 |
| 2019 | General | $244,784 | 152 |
| 2019 | Research | $141,784 | 4 |
Breakdown
The top 5 of 16 recipients; each share is of general payments naming this product in 2024.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
381 general · 817 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.